Fat Checking: Emerging Role of Lipids in Metabolism and Disease

Lipids are hydrophobic molecules involved in a plethora of biological functions; for example, they are employed for the storage of energy, serve as essential constituents of cell membranes and participate in the assembly of bilayer configuration [...]

Cholesterol metabolism is altered in Rett syndrome: A study on plasma and primary cultured fibroblasts derived from patients

Rett (RTT) syndrome is a severe neurological disorder that affects almost exclusively females. Several detectable mutations in the X-linked methyl-CpG-binding protein 2 gene (MECP2) are responsible for the onset of the disease. MeCP2 is a key transcription regulator involved in gene silencing via methylation-dependent remodeling of chromatin. Recent data highlight that lipid metabolism is perturbed in brains and livers of MECP2-null male mice. In addition, altered plasma lipid profile in RTT patients has been observed. Thus, the aim of the work is to investigate the protein network involved in cholesterol homeostasis maintenance on freshly isolated fibroblasts and plasma from both RTT and healthy donors. To this end, protein expression of 3-hydroxy-3methyl glutaryl Coenzyme A reductase (HMGR), sterol regulatory element binding proteins (SREBPs), low density lipoprotein receptor (LDLr) and scavenger receptor B-1 (SRB-1) was assessed in cultured skin fibroblasts from unaffected individuals and RTT patients. In addition, lipid profile and the abundance of proprotein convertase subtilisin/kexin type 9 (PCSK9) were analyzed on plasma samples. The obtained results demonstrate that the main proteins belonging to cholesterol regulatory network are altered in RTT female patients, providing the proof of principle that cholesterol metabolism may be taken into account as a new target for the treatment of specific features of RTT pathology

Short-Term Activation by Low 17β-Estradiol Concentrations of the Na+/H+ Exchanger in Rat Aortic Smooth Muscle Cells: Physiopathological Implications

Low physiological concentrations of 17β-estradiol increased the intracellular pH of rat aortic smooth muscle cells by a rapid nongenomic mechanism. This effect was due to stimulation of the Na+/H+ exchanger activity, measured using the intracellular pH-sensitive fluorescent probe 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein. The 17β-estradiol gave rise to a bell-shaped dose response, with a maximum at 10−12m and no significant effect at 10−9m. The specificity of the effect was verified by the use of the Na+/H+ exchanger inhibitor 5-(ethyl-N-isopropyl)amiloride and the lack of effect of the isomer 17α-estradiol. Inhibitors of the nuclear estrogen receptors, tamoxifen and ICI 182,780, completely prevented activation of the exchanger by 17β-estradiol. The effect of low estrogen concentrations on the intracellular pH was mimicked by both norepinephrine and phenylephrine, suggesting a connection between the increase of intracellular pH and the muscle contraction process. The transduction mechanism for this nongenomic effect of estrogens did not involve modulation of the cAMP content, whereas inositol 1,4,5-trisphosphate, protein kinase C and MAPK pathways appear to play a role, as indicated by both pharmacological approaches and immunoblot experiments on protein kinase C translocation and ERK phosphorylation. These results for the first time provide evidence for a nongenomic effect of low physiological concentrations of 17β-estradiol on intracellular pH that, together with other factors, may contribute to the development of hypertension and atherosclerosis in men and postmenopausal women and increase the risk of cardiovascular disease. Paradoxically, the lack of stimulation at high physiological estradiol levels could explain the protective effects found in premenopausal women

Sex differences in hepatic regulation of cholesterol homeostasis

Physiological sex differences may influence metabolic status and then alter the onset of some diseases. According to recent studies, it is now well established that females are more protected from hypercholesterolemia-related diseases, such as cardiovascular diseases until menopause. Female protection from hypercholesterolemia is mediated by the hypolipidemic properties of estrogens, even if mechanisms underlying this protection remain still debated. Even though the regulatory mechanisms of cholesterol homeostasis maintenance are well known, few data are available on the supposed differences between male and female in these processes. So, the aim of this work was to define, through an in vivo study, the putative sex-dependent regulation of the processes underlying cholesterol homeostasis maintenance. We examined 3-hydroxy 3-methylglutaryl coenzyme A reductase and its regulatory protein network as well as the amount of low-density lipoprotein receptor and cholesterol. The study was conducted in the liver and plasma of male and female rats, on adults and during postnatal development, and on 17-β-estradiol-treated male rats. Our data support that physiological differences in proteins involved in cholesterol balance are present between the sexes and, in particular, 3-hydroxy 3-methylglutaryl coenzyme A reductase shows lower activity and expression in female and 17-β-estradiol-treated male rats than in adult untreated male. Our data suggest that sex differences in enzyme expression depend on variation in regulatory proteins and seem to be related to estrogen presence. This work adds new evidence in the complicated picture of sex-dependent cellular physiology and establishes a new role for reductase regulatory proteins as a link between estrogen protective effects and cholesterol homeostasis

Prenatal Exposure to BPA: The Effects on Hepatic Lipid Metabolism in Male and Female Rat Fetuses

Bisphenol A (BPA) is an organic chemical compound widely used for manufacturing plastics. BPA exposure originates principally from the diet, but it can also originate from dermal contact. In over 90% of individuals, including pregnant women, BPA is detectable in several body fluids. The effects of this exposure on the fetus are under active investigation in several research laboratories. The aim of our work was to study the impact of prenatal exposure to BPA in the liver of rat fetuses from a sex-dependent point of view. We particularly investigated the effects of prenatal BPA exposure on hepatic lipids because of their crucial role, not only for the liver, but also for the whole-body functions. Our results demonstrate that the liver of rat fetuses, in utero exposed to a very low dose of BPA (2.5 µg/kg/day), displays significant modulations with regard to proteins involved in cholesterol and fatty acid biosynthesis and trafficking. Moreover, an impact on inflammatory process has been observed. All these effects are dependent on sex, being observable only in female rat fetuses. In conclusion, this work demonstrates that maternal exposure to BPA compromises hepatic lipid metabolism in female offspring, and it also reveals the perspective impact of BPA on human health at doses currently considered safe

Nuclear Shield: A Multi-Enzyme Task-Force for Nucleus Protection

In eukaryotic cells the nuclear envelope isolates and protects DNA from molecules that could damage its structure or interfere with its processing. Moreover, selected protection enzymes and vitamins act as efficient guardians against toxic compounds both in the nucleoplasm and in the cytosol. The observation that a cytosolic detoxifying and antioxidant enzyme i.e. glutathione transferase is accumulated in the perinuclear region of the rat hepatocytes suggests that other unrecognized modalities of nuclear protection may exist. Here we show evidence for the existence of a safeguard enzyme machinery formed by an hyper-crowding of cationic enzymes and proteins encompassing the nuclear membrane and promoted by electrostatic interactions

XQR-30: the ultimate XSHOOTER quasar sample at the reionization epoch

The final phase of the reionization process can be probed by rest-frame UV absorption spectra of quasars at z>6, shedding light on the properties of the diffuse intergalactic medium within the first Gyr of the Universe. The ESO Large Programme "XQR-30: the ultimate XSHOOTER legacy survey of quasars at z~5.8-6.6" dedicated ~250 hours of observations at the VLT to create a homogeneous and high-quality sample of spectra of 30 luminous quasars at z~6, covering the rest wavelength range from the Lyman limit to beyond the MgII emission. Twelve quasar spectra of similar quality from the XSHOOTER archive were added to form the enlarged XQR-30 sample, corresponding to a total of ~350 hours of on-source exposure time. The median effective resolving power of the 42 spectra is R~11400 and 9800 in the VIS and NIR arm, respectively. The signal-to-noise ratio per 10 km/s pixel ranges from ~11 to 114 at $\lambda \simeq 1285$ \AA rest frame, with a median value of ~29. We describe the observations, data reduction and analysis of the spectra, together with some first results based on the E-XQR-30 sample. New photometry in the H and K bands are provided for the XQR-30 quasars, together with composite spectra whose characteristics reflect the large absolute magnitudes of the sample. The composite and the reduced spectra are released to the community through a public repository, and will enable a range of studies addressing outstanding questions regarding the first Gyr of the Universe.Comment: 21 pages, 10 figures. Revised version resubmitted to MNRAS after minor referee repor

Role of mevalonate pathway in the central nervous system

La voie biosynthétique du mevalonate (MVA) est indispensable à la production de molécules qui sont essentielles dans grand nombre de processus physiologiques mais la plupart des études effectuées sur le rôle physiologique de cet important processus métabolique dans le système nerveux central restent simplement en corrélation. Pour autant, le but des études présentées dans cette thèse a été: évaluer les protéines de la voie du MVA dans différentes régions du cerveaux de rat en prenant en considération l’éventuelle modulation selon le sexe et l’âge; analyser l’impact de la voie sur le développement des neurones set sur le comportement des rats; explorer l’impact de la voie dans une pathologie du neurodéveloppement comme l’autisme. Les résultats démontrent que la voie biosynthétique du MVA est régulée différemment selon la région du cerveau analysée, en fonction de l’âge et du sexe. La voie biosynthétique du MVA revêt un rôle critique dans la modulation physiologique du comportement animal et du développement des neurones Pour finir, mes données démontrent, dans un modèle expérimental d’autisme, que la voie biosynthétique du MVA est modulée dans plusieurs région du SNC selon l’âge.The mevalonate (MVA) pathway is an essential metabolic pathway that leads to the production of molecules important in several physiological processes and play pivotal roles in the brain. An imbalance of this pathway in CNS is accompanied by the onset of several neuropathological descriptions. Despite these observations, the physiological importance of this metabolic process in the brain has remained unclear. My aim was to study the presence and the regulation of the proteins involved in the MVA pathway in different rat brain areas in a sex- and age-dependent manner, to analyze the impact of the key enzymes on neuronal development and on rat behavior, and to explore whether the MVA pathway is affected in a neurodevelopmental disease such as autism. My results demonstrate that this metabolic process is expressed and modulated in a highly region-dependent manner and that age and sex induce physiological differences. Notably, it impact on behavior and neuronal development suggesting that this pathway may be considered as potential molecular target when designing novel therapeutic approaches for the treatment of these pathologies

Rôle de la voie mévalonate dans le système nerveux central

The mevalonate (MVA) pathway is an essential metabolic pathway that leads to the production of molecules important in several physiological processes and play pivotal roles in the brain. An imbalance of this pathway in CNS is accompanied by the onset of several neuropathological descriptions. Despite these observations, the physiological importance of this metabolic process in the brain has remained unclear. My aim was to study the presence and the regulation of the proteins involved in the MVA pathway in different rat brain areas in a sex- and age-dependent manner, to analyze the impact of the key enzymes on neuronal development and on rat behavior, and to explore whether the MVA pathway is affected in a neurodevelopmental disease such as autism. My results demonstrate that this metabolic process is expressed and modulated in a highly region-dependent manner and that age and sex induce physiological differences. Notably, it impact on behavior and neuronal development suggesting that this pathway may be considered as potential molecular target when designing novel therapeutic approaches for the treatment of these pathologies.La voie biosynthétique du mevalonate (MVA) est indispensable à la production de molécules qui sont essentielles dans grand nombre de processus physiologiques mais la plupart des études effectuées sur le rôle physiologique de cet important processus métabolique dans le système nerveux central restent simplement en corrélation. Pour autant, le but des études présentées dans cette thèse a été: évaluer les protéines de la voie du MVA dans différentes régions du cerveaux de rat en prenant en considération l’éventuelle modulation selon le sexe et l’âge; analyser l’impact de la voie sur le développement des neurones set sur le comportement des rats; explorer l’impact de la voie dans une pathologie du neurodéveloppement comme l’autisme. Les résultats démontrent que la voie biosynthétique du MVA est régulée différemment selon la région du cerveau analysée, en fonction de l’âge et du sexe. La voie biosynthétique du MVA revêt un rôle critique dans la modulation physiologique du comportement animal et du développement des neurones Pour finir, mes données démontrent, dans un modèle expérimental d’autisme, que la voie biosynthétique du MVA est modulée dans plusieurs région du SNC selon l’âge

Role of mevalonate pathway in the central nervous system

La voie biosynthétique du mevalonate (MVA) est indispensable à la production de molécules qui sont essentielles dans grand nombre de processus physiologiques mais la plupart des études effectuées sur le rôle physiologique de cet important processus métabolique dans le système nerveux central restent simplement en corrélation. Pour autant, le but des études présentées dans cette thèse a été: évaluer les protéines de la voie du MVA dans différentes régions du cerveaux de rat en prenant en considération l’éventuelle modulation selon le sexe et l’âge; analyser l’impact de la voie sur le développement des neurones set sur le comportement des rats; explorer l’impact de la voie dans une pathologie du neurodéveloppement comme l’autisme. Les résultats démontrent que la voie biosynthétique du MVA est régulée différemment selon la région du cerveau analysée, en fonction de l’âge et du sexe. La voie biosynthétique du MVA revêt un rôle critique dans la modulation physiologique du comportement animal et du développement des neurones Pour finir, mes données démontrent, dans un modèle expérimental d’autisme, que la voie biosynthétique du MVA est modulée dans plusieurs région du SNC selon l’âge.The mevalonate (MVA) pathway is an essential metabolic pathway that leads to the production of molecules important in several physiological processes and play pivotal roles in the brain. An imbalance of this pathway in CNS is accompanied by the onset of several neuropathological descriptions. Despite these observations, the physiological importance of this metabolic process in the brain has remained unclear. My aim was to study the presence and the regulation of the proteins involved in the MVA pathway in different rat brain areas in a sex- and age-dependent manner, to analyze the impact of the key enzymes on neuronal development and on rat behavior, and to explore whether the MVA pathway is affected in a neurodevelopmental disease such as autism. My results demonstrate that this metabolic process is expressed and modulated in a highly region-dependent manner and that age and sex induce physiological differences. Notably, it impact on behavior and neuronal development suggesting that this pathway may be considered as potential molecular target when designing novel therapeutic approaches for the treatment of these pathologies